User:Mr. Ibrahem/Maribavir

Maribavir, sold under the brand name Livtencity, is an antiviral medication used to treat post-transplant cytomegalovirus (CMV). Specifically it is used in cases where ganciclovir, valganciclovir, cidofovir, and foscarnet are not effective. It is taken by mouth.

Common side effects include taste disturbance, nausea, diarrhea, vomiting, and fatigue. Safety in pregnancy is unclear. It is a cytomegalovirus pUL97 kinase inhibitor thus blocks virus replication.

Maribavir was approved for medical use in the United States in 2021. As of 2022 it has been recommended for approval in Europe. In the United States 4 weeks costs about 25,000 USD as of 2022.